Avadel AVDL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Avadel AVDL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (18)	5/24/2003 12:38:04 PM
From: Brander	Read Replies (1) of 240

Hi TD, Just changing the color of a pill has never been enough to extend a patent. Using different coatings in a way that changes a drug to an extended release formulation, for example, has been used to extend patents. Other things drug companies are doing are coming out with oral dissolving forms of their pills that are about to go generic, developing specific isomers of their soon to be generic drugs, and other creative ideas. They are looking for methods that don't cost too much, but change the drug enough to be granted an extension of their valuable patents. The potential market for anyone that can offer the drug companies a capable and cost efficient technology that helps them extend the patents on their block busters is obviously very large.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next